JJ
Jay Jeffrey R
Long-term holderQuality / disciplined sizingDiversified strategy
Total reported value
$126.5M
Reporting period: 2013-06-30 · Number of holdings: 32
JAY JEFFREY R disclosed 32 holdings in its latest 13F filing for the period ending 2013-06-30, with total reported value of $126.5M and a quarterly turnover rate of 0.0%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "J"
Personality snowflake
- Concentration
- 31.16
- Portfolio Stability
- 0
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 64
- Sizing Uniformity
- 87.59
Recent moves
No holding changes this quarter
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Hyperion Therapeutics INC | Stock-Other | 16.76% | — | — | — |
| 2 | ✓ | Furiex Pharmaceuticals | Stock-Other | 13.30% | — | — | — |
| 3 | STMLEUR | Stemline Therapeutics INC | Stock-Other | 11.22% | — | — | — |
| 4 | ✓ | Biodel INC | Stock-Other | 6.12% | — | — | — |
| 5 | ✓ | Ambit Biosciences CORP | Stock-Other | 5.53% | — | — | — |
| 6 | GERN | Geron CORP | Stock-Other | 4.45% | — | — | — |
| 7 | ✓ | Pain Therapeutics INC | Stock-Other | 4.06% | — | — | — |
| 8 | ✓ | Sunshine Heart INC | Stock-Other | 4.03% | — | — | — |
| 9 | ✓ | Durata Therapeutics INC | Stock-Other | 3.64% | — | — | — |
| 10 | ✓ | Nordion INC | Stock-Other | 3.14% | — | — | — |
| 11 | ✓ | Horizon Pharma INC | Stock-Other | 3.10% | — | — | — |
| 12 | ✓ | Oncogenex Pharmaceuticals In | Stock-Other | 2.69% | — | — | — |
| 13 | IPXLEUR | Impax Laboratories INC | Stock-Other | 2.36% | — | — | — |
| 14 | TRIBGBP | Trinity Biotech Plc-spon Adr | Stock-Other | 2.17% | — | — | — |
| 15 | RTIXEUR | Rti Surgical Hds INC | Stock-Other | 2.00% | — | — | — |
| 16 | ✓ | Dyax CORP | Stock-Other | 1.99% | — | — | — |
| 17 | ✓ | Mast Therapeutics INC | Stock-Other | 1.97% | — | — | — |
| 18 | PLX1EUR | Protalix Biotherapeutics INC | Stock-Other | 1.55% | — | — | — |
| 19 | MYGN | Myriad Genetics INC | Stock-Other | 1.49% | — | — | — |
| 20 | ✓ | Volcano Corporation | Stock-Other | 1.43% | — | — | — |
| 21 | ✓ | Targacept INC | Stock-Other | 1.24% | — | — | — |
| 22 | ✓ | Avanir Pharmaceuticals INC | Stock-Other | 0.94% | — | — | — |
| 23 | ✓ | Xenoport INC | Stock-Other | 0.91% | — | — | — |
| 24 | MEIPUSD | Lite Strategy INC | Stock-Other | 0.89% | — | — | — |
| 25 | ✓ | Pernix Therapeutics Holdings | Stock-Other | 0.85% | — | — | — |
| 26 | ✓ | Stock-Other | 0.84% | — | — | — | |
| 27 | ✓ | Vascular Solutions INC | Stock-Other | 0.54% | — | — | — |
| 28 | ✓ | Wright Med Group INC | Stock-Other | 0.43% | — | — | — |
| 29 | ✓ | Celsion Corporation | Stock-Other | 0.15% | — | — | — |
| 30 | AORT | Artivion INC | Stock-Other | 0.13% | — | — | — |
| 31 | GWPH | Gw Pharmaceuticals LTD | Stock-Other | 0.08% | — | — | — |
| 32 | AMAG | Amag Pharmaceuticals INC | Stock-Other | — | — | — | — |
Reported value over time
Not enough data yet to compute personality scores
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Not enough sector-mapped data yet
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2013-06-30 | 32 | $126.5M | 0 |
Holding changes this quarter
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
FAQ
What is Jay Jeffrey R and what type of investor is it?
Jay Jeffrey R is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2013-06-30), the firm manages a tracked equity portfolio valued at approximately $126.5M, spread across 32 disclosed positions.
What are Jay Jeffrey R's largest equity positions?
Based on the latest 13F filing, Jay Jeffrey R's top holdings by market value are:
1. Hyperion Therapeutics INC — $21.2M (16.8%)
2. Furiex Pharmaceuticals — $16.8M (13.3%)
3. Stemline Therapeutics INC (STMLEUR) — $14.2M (11.2%)
4. Biodel INC — $7.7M (6.1%)
5. Ambit Biosciences CORP — $7.0M (5.5%)
What changes did Jay Jeffrey R make in its most recent portfolio filing?
No notable portfolio changes were recorded for Jay Jeffrey R in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Jay Jeffrey R focus on?
Sector breakdown data is not yet available for Jay Jeffrey R. Check back after the next 13F processing cycle.
Peer Institutions
Institutions with a similar AUM
AS
Ares Systematic Credit Ltd
Total reported value
$126.6M
150 stks
2026-03-31
Concentration5.9
Portfolio Stability100.0
Sector conviction100.0
AUM within 0.0% of this institution
View detail
RF
Roxbury Financial LLC
Total reported value
$126.5M
410 stks
2026-06-30
Concentration0.0
Portfolio Stability0.0
Sector conviction46.3
AUM within 0.1% of this institution
View detail
LM
Legg Mason, INC.
Total reported value
$126.6M
7 stks
2020-06-30
Concentration100.0
Portfolio Stability100.0
Sector conviction0.0
AUM within 0.1% of this institution
View detail